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Introduction 
   
Since the beginning of time, mankind has always admired salmon.
1
 Salmon work 
hard, persevere in the face of adversity, and brave terrible peril just to complete 
seemingly pointless tasks. The salmon’s quixotic journey back to its birthplace is both 
inspirational and  the subject of allegory. However, mankind has also admired salmon for 
more than simply its inspirational story. Instead, humanity has found a much more useful 
quality in salmon:  they are very nutritious. Families in the United States consume 
284,000 metric tons of salmon annually
2
, which is close to two pounds per capita, second 
only to shrimp and tuna for fish consumption.
3
 
 Unfortunately, salmon have been overfished, and their numbers in the wild have 
been declining rapidly.
4
 Some might say that the best way to combat this problem would 
be to change the way we fish, or to change our eating habits, or possibly to help the 
salmon reproduce in some way. But those solutions are difficult?, and often they do not 
yield huge success. Recently AquaBounty,
5
 an English biotechnology company, found 
                                                        
1 Orin S. Kerr, A Theory of Law, 16 GREEN BAG 2d 111 (2012). 
2 University of Alaska Anchorage Institute of Social and Economic Research, Overview of US Salmon 
Consumption, 
http://www.iser.uaa.alaska.edu/Publications/greatsalmonrun/SalmonReport_Ch_8.pdf 
3 AboutSeafood.com, Top 10 Consumed Seafoods, http://www.aboutseafood.com/about/about-
seafood/top-10-consumed-seafoods 
4 George Kimbrell, Paige Tomaselli, A "Fisheye" Lens on the Technological Dilemma: The Specter of 
Genetically Engineered Animals, 18 Animal L. 75, 77 (2011).   
5 AquaBounty Technologies was originally incorporated in 1991 under the name A/F Protein, to 
pursue the commercial development of antifreeze protein-based technology under license from the 
University of California at Berkeley. Reorganized in 2000, it was divided into two separate entities:  
A/F Protein, which retained the antifreeze protein technology; and, AquaBounty Farms, which 
obtained the AquAdvantage® technology. This is the current organization of the company 
AquaBounty Technologies, The Company, http://www.aquabounty.com/company/company-history-
292.aspx. 
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another solution to this problem. Resolving to bring “together biological sciences and 
molecular technology to enable an aquaculture industry capable of large-scale, efficient, 
and environmentally sustainable production of high quality seafood,” AquaBounty’s 
solution uses genetic modification to create a completely new salmon from scratch, 
infused with genetic abnormalities from two other fish. This newly created salmon, called 
the AquAdvantage Salmon (AAS), grows to over four times the size of naturally 
producing salmon, due to the genetic modification of AquaBounty in the zygote stage of 
the salmon’s development.6 
 The zygote stage of development is the earliest developmental stage of complex, 
or multi-celled organisms. This is an extremely critical part of the development of 
complex organisms, because the zygote contains all the genetic information that will 
define the organism for the rest of its life. Once solidified, this genetic blueprint will be 
copied and divided into the millions of cells that make up complex organisms, such as 
humans or salmon. The reason that this stage is extremely critical and highlighted in this 
paper is because modification of the genetic structure during this stage of development 
will forever change the genetic structure of the developing and adult organism. No further 
human intervention would be necessary, because without anything further, all genetic 
material would  be copied and reproduced in the organism by the process of life itself. 
The organism would live its life as normal, without needing constant human supervision 
or upkeep.
7
 
                                                        
6 Matthew Morgan, The AquAdvantage Salmon: Who Owns Escaped Genetically Modified Animals?, 17 
OCEAN & COASTAL L.J. 127, 128 (2011).  How much of your paper mirrows this article?? 
7 In this specific case, scientists are modifying the zygote to add genetic material that they believe will 
beneficial to salmon. Once altered, scientists do not need to do anything to accommodate the changes 
that they have made in the salmon (aside from those societal and environmental ones discussed in 
this note). 
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 AquaBounty accomplishes this genetic modification by taking a fertilized egg and 
adding two genes from two different fish. The first gene comes from a Chinook salmon 
and promotes uninhibited growth “when microinjected into fertilized, non-activated 
Atlantic salmon eggs.”8 Normally, salmon stop growing once they get to a certain size, 
because they have trouble swimming back upstream if they are not streamlined.
9
 But  
Chinook salmon spawns in deeper and larger waters than other salmon species, and they 
return upriver less often than other salmon species. Thus their thyroid (the growth 
facilitator) allows them to grow to much larger sizes.
10
 When the Chinook’s growth gene 
is inserted into an AAS salmon, that salmon’s thyroid will never inhibit the salmon from 
growing, thus allowing it to grow to four times its normal size.
11
 
 The second gene that is added to AAS comes from the ocean pout.
12
 The ocean 
pout has anti-freezing proteins in its blood, allowing it to live in waters close to the 
freezing point.
13
 This gene keeps the pout’s blood thick, and it allows more of the 
Chinook’s growth gene to flow through the AAS.14 Additionally, salmon naturally only 
grow in the spring and summer, because the waters in which they swim in the fall and 
winter are too cold to promote growth.
15
 The AAS with the pout’s anti-freezing gene 
does not have this problem and is able to grow throughout the cold seasons.
16
 This again 
allows the salmon to grow much faster than naturally occurring salmon are able to 
                                                        
8 US PAT 5545808, col.5 ls.8-9. 
9 The Pacific States Marine Fisheries Commission, Chinook Salmon, 
http://www.psmfc.org/habitat/edu_chinook_facts.html 
10 Id. 
11 Morgan, 17 OCEAN & COASTAL L.J. at 128. 
12 Katherine Wilinska, 21 MINN. J. INT'L L.  at 148.  Not proper cite.  
13 James Gorman, Dumb and Dumber:  Here’s a Fish Story With Legs, N.Y. Times, September 22, 2002. 
14 Morgan, 17 OCEAN & COASTAL L.J. at 128. 
15 Id. 
16 Id. 
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grow.
17
 The combination of these genes allows AquaBounty’s AAS to massively outgrow 
naturally fished and farmed salmon. AquaBounty’s patent application boasts that “[a]t 
eight months old, the average increase of the transgenic fish was 4-fold and the largest 
transgenic fish was eight times bigger than the non-transgenic controls.”18  
All of this modification occurs at the zygote stage of the salmon’s development. 
Thus, the salmon is allowed to develop naturally, as in nature, for the rest of its life (aside 
from the fact that the development itself is not natural). In essence, the AAS is almost? 
exactly the same as a naturally occurring salmon,
19
 save for the beneficial meddling? of 
scientists in its fertilized egg. 
The FDA recently decided that AAS are safe for human food production,
20
 
although some critics have voiced concern over this decision. Despite the FDA’s 
approval, some remain concerned that the salmon should not be produced for human 
consumption; that the consequences to the environment of the salmon escaping would be 
disastrous; and that allowing these salmon to be produced would seriously affect the 
fishing industry and their place in that industry, including the export to Europe. Aside 
from not allowing the salmon to be produced, these people are calling for more regulation 
of genetically modified food, including requiring a consumer label to be applied to all 
genetically modified food. Though arguably these might be valid concerns, this paper 
will assert that the FDA should not take a larger interest in regulating genetically 
                                                        
17 Id. 
18 US PAT 5545808, col.5 ls.13-16. 
19 The only difference in the salmon is the insertion of positive genetic traits. Were the salmon to be 
cognizant, they would not know they were different than other salmon. Nor would anyone be able to 
tell simply by looking at them. 
20 FDA, VMAC Briefing Packet, AquAdvantage Salmon,  
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/VeterinaryMe
dicineAdvisoryCommittee/UCM224762.pdf 
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engineered salmon because, when raised for consumption, genetically engineered salmon 
pose no substantial threat to humans or the environment. 
Discussion 
 A.  Escape and environmental impact 
The first concern voiced by AquAdvantage critics is that the impact of their AAS 
escaping from their tanks would be disastrous to the environment.
21
 These critics point to 
studies by the National Academy of Sciences and the EU, which conclude that 
genetically modified fish will have a higher tolerance for environmental stressors, and 
they will be better equipped therefore to survive in ecosystems where they previously 
were unable to thrive.
22
 They also attack the FDA’s safety evaluation, asserting that the 
FDA was “too simplistic” in its environmental impact assessment, because “history 
dictates that fish held in aquaculture facilities…[inevitably] escape.”23 
Usually, the risk of escape is very legitimate, because it actually does happen. 
Conventionally, far- raised fish are contained in an “open system”.24 Open systems are 
connected to the ocean or stream, salt or fresh water—wherever the fish need to be 
raised. Open systems are basically pens for the fish, constructed with nets designed to 
keep them from going into the open waters of the ocean or stream.
25
 In conventional 
                                                        
21 See e.g. Kimbrell, Paige Tomaselli, A "Fisheye" Lens on the Technological Dilemma: The Specter of 
Genetically Engineered Animals, 18 ANIMAL L. 75 (2011). 
22 Id. at 80.  Should explain EU and what its concerns are 
23 Id. 
24 Morgan, 17 OCEAN & COASTAL L.J. at 133. 
25 Kimbrell, 18 ANIMAL L. at 77. 
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systems, escaping fish are an inescapable conclusion, because of natural failure of the 
containment, human intervention, or a host of other reasons.
26
 
There are indeed? a few environmental problems with escaping farmed salmon, 
leading to a documented decline in the salmon population because of these escapes.
27
 It is 
an obvious proposition that when humans introduce animals into the wild that have 
previously been farmed and fed, this negatively impacts the wild population of that 
animal (and may likely harm the ecosystem as a whole).  
Escaped fish could first impact the wild salmon population by increasing 
competition for food and breeding sites.
28
 Second, the farmed fish are not a strong or 
naturally fit as wild fish. When they escape and the two interbreed, the wild population 
loses its fitness edge and becomes a weaker fish.
29
 Combined with more competition for 
resources, the weakening wild population inevitably begins to lose its competitive edge in 
the ecosystem, and the salmon numbers and nutritional value begin to decline.
30
 Though 
inescapable, the risk of this declining wild population is considered manageable, because 
the escape rate of farmed salmon is only at around 1%, allowing a low enough threshold 
ro prevent substantial collateral damage.
31
 
It is possible, however, for salmon fisheries to be subject to even greater 
restrictions on their escape rate. Technology exists  for the fisheries to create better 
containment systems, which is exactly what AquaBounty has done with its AAS. 
AquaBounty thus far has kept their fish in inland tanks to minimize the risks of their 
                                                        
26 Id. 
27 Kimbrell, 18 ANIMAL L. at 78. 
28 Id. 
29 Id. 
30 Id. 
31 Wilinska, 21 MINN. J. INT'L L. at 163. 
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salmon escaping and releasing themselves into the wild.
32
 Because these tanks have no 
direct contact with rivers, streams, or any inlet that might lead to an ocean or wild salmon 
population, AquaBounty has much greater control over their salmon and the effectiveness 
of their controlled system.
33
  
AquaBounty’s closed system has multiple redundant containment systems, 
including steel screens, additional jump fences, and lethal chemicals in the escape zones 
and drain areas to immediately dispose of the salmon should they happen to escape the 
other redundant feaatures.
34
 Naturally, even with multiple redundant security systems, 
there is still a chance of salmon escaping. But the only way that this could happen would 
be through natural disasters
35
, human intervention
36
, or mechanical failures.
37
 Indeed, 
even should these containment features fail, the eggs are currently being grown thousands 
of miles away from the nearest salmon population, e.g. in the Panamanian highlands.fn 
Thus it appears that the probability of a single fish escaping containment and travelling 
thousands of nautical miles through heavily predator infested waters, mating, and 
spawning with enough proficiency to cause an epidemic that would decimate large 
populations of wild salmon seems so infinitesimal so as to be disregarded.
38
 Additionally, 
this geographical containment features waters in which the salmon would not be able to 
survive because of their extreme temperatures. They would also probably run into actual 
                                                        
32 Id. 
33 Morgan, 17 OCEAN & COASTAL L.J. at 134.  
34 Id. 
35 Force Majeur, ??e.g. floods, tornadoes/hurricanes, earthquakes, etc. 
36 E.g. negligence, theft, sabotages. 
37 Id. Mechanical failures may include errors or disasters in shipping eggs or mishandling or 
improper disposal of samples. There are many points along the line aside from the containment that 
might be vulnerable to mistake or human error. 
38 Id.  Id.?? to what 
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hydro-electric power plants between the salmon and the nearest wild salmon population, 
further compounding the salmon’s ability to escape and do actual damage to the wild.39 
Finally, critics still suppose that should the unthinkable happen, that some of the 
contained salmon actually escape and insert themselves into a wild salmon population, 
the results would be much more devastating than when farmed salmon escape. There is 
no doubt that these genetically modified salmon would outcompete natural salmon for 
resources.
40
 They would be bigger, faster, and would have a better ability to get at the 
natural resources.
41
 Additionally, they would need more resources to survive because of 
their size, so a single AAS would not only be replacing a single wild salmon.?? The AAS 
would consume? the resources of several wild salmon to sustain itself, thereby drastically 
reducing the numbers of wild salmon by sheer numbers and competition.
42
 
Additionally, the release of AAS into the wild would most likely cause what 
scientists have dubbed the “Trojan gene” effect.43 AAS would have an enhanced ability 
to mate, because of their size and strength. However, AAS also have reduced viability as 
adults simply because they need so many resources to survive. Thus, when the AAS 
releases the Trojan gene into the wild population, each successive generation of fish 
would be less viable than their parent generation.
44
 The salmon would become more 
aggressive, would have to change their breeding patterns, and ultimately would have to 
change their migration patterns, making them less successful and viable for all of these 
                                                        
39 Id. 
40 Kimbrell, 18 Animal L. at 80. 
41 Id. 
42 Id.  
43 Id. at 81. 
44 Id. 
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things.
45
 The less viable wild salmon population would therefore not be able to live up to 
the survival of the fittest, and wiould be eventually completely destroyed.
46
 Some 
scientists estimate that salmon could be extinct in less than 40 generations, should the 
AAS allow the Trojan gene to run rampant in wild salmon populations.
47
 This “Trojan 
gene” scenario is not the only, but is the worst scenario? that the CABI or any scientific 
study has been able to postulate, and it is only a theoretical “high risk scenario” in which 
the GM fish outcompetes the wild fish for reproductive opportunities, only to have far 
weaker post-reproduction survival skills-leading to a collapse of entire wild stocks.”48 
AquaBounty has introduced an additional redundant layer of containment into 
their AAS for just this reason. Even if their AAS were able to escape and overcome the 
significant odds that they would be killed before they could even come close to a wild 
population, they could not reproduce, because of two reasons:  All the AAS are female, 
and all the AAS are sterile.
49
 All female AAS is a function of the genetic process that 
AquaBounty uses to create the salmon. Because of the process, all the AAS are triploid.
50
 
Because all the fish have three X chromosomes, they all must be female. The third 
chromosome also renders them close to 100% sterile, because it is such a genetic 
abnormality.
51
 Analysis has confirmed that less than 1% of all AAS are sterile, and 100% 
are female.
52
 
                                                        
45 Kimbrell, 18 Animal L. at 82. Should use supra & proper citations.  
46 Id.  
47 Id. 
48 Morgan, 17 Ocean & Coastal L.J. at 161. 
49 Id. at 134. 
50 Id.  
51 Michael Bennett Homer, Frankenfish It's What's for Dinner: The FDA, Genetically Engineered Salmon, 
and the Flawed Regulation of Biotechnology, 45 COLUM. J.L. & SOC. Probs. 83, 116 (2011). 
52 Morgan, 17 OCEAN & COASTAL L.J. at 161. Should use supra citation instead of repeating title. 
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Because AquaBounty has created a closed system, there is an infinitesimal chance 
that the AAS will escape their containment. Because of the geographic containment 
feature of containment, there is also an infinitesimal chance that if the AAS somehow 
escape their facility containment they would be able to even come close to another, wild 
population of salmon. Finally, because of the triploid biologic features of the fish, there is 
less than a 2% chance that the fish will be sterile, and there is a 100% chance that the fish 
will all be female. Combining all these probabilities, the chance of escape and survival to 
endanger a natural salmon population is effectively zero, and there should be no reason to 
fear any disastrous effects of what would happen if the AAS were able to escape their 
containment. 
B.  Modified Food In General  
In 2000, the Department of Agriculture did a study on all of the genetically 
modified foods present in America. Their findings among other things, were that 25% of 
all corn, 54% of all soybeans, and 61% of all cotton planted in the United States had been 
modified in some way or another.
53
 However, these findings proved premature if taken to 
be completely indicative of the extent? of genetically modified food sold in the United 
States. The very next year, these percentages increased to 88%, 94%, and 90%, 
respectively.
54
 Of course, this only reflects the numbers of corn, soybeans, and cotton. 
Other recent estimates show that close to 75% of all processed foods that consumers 
purchased in supermarkets contains genetically engineered ingredients.
55
 Generally, there 
is no significant difference between these genetically modified productsand the 
                                                        
53 Homer, 45 COLUM. J.L. & SOC. PROBS. at 83. 
54 Id. 
55 Id. 
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originals?, and only about one0in-three Americans realize the fact that most of the food 
they eat has already been genetically modified.
56
 Genetic engineering helps to enhance 
agricultural efficiency, increase the amount and ability of crops to survive and that will 
survive, reduce the amount of food needed to be grown and the space that it will need to 
grow, as well as many other helpful things.
57
 {Do we know for sure that there are no long 
term effects?  Doesn’t it depend to some degree about what methods and ingredients are 
used to create the modification.  What is put into soybeans is not the same as used to 
genetically alter salmon.] 
However, not everyone sees these modifications as unequivocally good things. 
Some critics worry about the technological uncertainties of genetic engineering and the 
effects that the foods will have not only on humans who consume them, but also the 
environment in which they are grown.
58
 Critics fear a loss of biodiversity by extinction of 
species. These arguments are much the same as arguments from those worried about the 
wild salmon population being destroyed. Why are they the same?  Because you think 
they are groundless? They are not as forceful, however, because no one really seems to 
care as much about plants as animals, and humankind has been genetically modifying 
plants since we discovered that we were able to graft plants together. These critics have 
asked the federal government for more regulation and oversight in the production of 
genetically modified foods.
59
 
Up to now, this kind of oversight and regulation has not been the United States’ 
preferred method of dealing with genetically modified foods. Consumers have been 
                                                        
56 Wilinska, 21 Minn. J. Int'l L. at 151. 
57 See e.g. Homer, 45 COLUM. J.L. & SOC. PROBS.  Improper footnotes 
58 Id. 
59 Id. 
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traditionally more tolerant of genetic modification, assumedly for the reasons espoused 
above.
60
 Genetically modified foods have been subjected to a lenient regulatory 
framework within the United States, perhaps? because of the general approach that these 
foods should not be assumed harmful until evidence is presented to the contrary.
61
 
This approach has been referred to as “The Equivalence Principle”.62 The United 
States policy regarding most new products has always had a mind toward risk. 
Essentially, in US jurisprudence, [this is not jurisprudence!!] this principle assumes that if 
a genetically enhanced product is essentially or substantially equivalent to its underlying, 
natural product, there should be no significant adverse effect on its production or 
consumption.
63
 The FDA’s statement of its own position reflects this:  Transgenic foods 
are “generally recognized as safe,” until proven otherwise.64 As scholars point out, this 
more or less means that the introduction of genetically modified products into consumer 
markets is controlled by free market principles.
65
 This allows quicker and more exact 
scientific progress, and ultimately allows for better products to reach consumer markets  
faster. 
C. Regulation of Genetically Modified Foods 
Approximately 25 percent of all consumer products marketed in the United States 
are overseen and approved by the FDA.
66
 Congress, in enacting legislation delegating 
oversight power to the FDA, has created statutorily defined classes of products that the 
                                                        
60 Wilinska, 21 MINN. J. INT'L L. at 163 (2012) 
61 Id. 
62 Id. 
63 Id.  
64 George Kimbrell, Paige Tomaselli, A "Fisheye" Lens on the Technological Dilemma: The Specter of 
Genetically Engineered Animals, 18 Animal L. 75, 97 (2011). 
65 See e.g. Wilinska, 21 MINN. J. INT'L L. at 163. 
66 FDA, Advancing Regulatory Science at FDA: A Strategic Plan (2011), available at 
http://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm267719.htm. 
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FDA can regulate. Because of this approach of categorizing every consumer product 
class, the legal and regulatory framework in which the FDA analyzes each new product 
varies according to which statutory category that a new product will fit into.
67
 This means 
that rather than taking oversight over the processes by which food and drugs are allowed 
to enter into the market, the FDA really only takes control of the actual products 
themselves. While this may have been a good approach to organizing the FDA’s 
authority when the Food, Drug, and Cosmetic Act (FDCA)
68
 was enacted, it makes it 
increasingly difficult for FDA regulations to keep up with emerging technologies and 
scientific progress when it comes to new products.
69
  
Many commentators have expressed concern with how this affects the amount of 
regulation that the FDA actually has over the entrance of technologically.
70
 Regardless of 
how valid or invalid these criticisms may be regardiing this (arguably) inflexible statutory 
framework, the FDA has asserted authority over genetically modified animals under 
interpretation of several statutes codified from the FDCA.
 71
 Additionally, the FDA has 
provided explanation their own internal documents concerning administrative procedure 
and authority.
72
  Unclear?? 
The FDA first has authority to regulate genetically modified animal products, 
because it already regulates “new animal drugs”, whether or not these animals are used 
                                                        
67 Jordan Paradise & Ethan Fitzpatrick, Synthetic Biology: Does Re-Writing Nature Require Re-Writing 
Regulation?, 117 PENN ST. L. REV. 53, 63 (2012). 
68 See generally 21 U.S.C. § 301 et seq. 
69 Supra Paradise, n.67.  not proper cite 
70 See e.g. Susan B. Foote & Robert J. Berlin, Can Regulation Be as Innovative as Science and 
Technology? The FDA's Regulation of Combination Products, 6 MINN. J. L. SCI. & TECH. 619, 623 (2005). 
71 71 See generally 21 U.S.C. § 301 et seq. 
72 See generally e.g. FDA, Genetically Engineered Animals, http:// 
www.fda.gov/AnimalVeterinary/DevelopmentApprovalProcess/GeneticEngineering/GeneticallyEngi
neeredAnimals/ default.htm; See also A Strategic Plan, supra n.65. 
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for human consumption.
73
 As defined by federal statute, new animal drugs include “any 
drug intended for use for animals other than man, including any drug intended for use in 
animal feed but not including such animal feed.”74 Though recombinant DNA (rDNA) 
might not seem like a drug to a layperson, the process is applied to animals in the same 
way as a conventional drug might be, and the FDA considers the two effectively the 
same.
75
 Unclear   
Last year, the FDA released guidance regarding this position, and in the most 
relevant part stated, “an rDNA construct is in a GE animal and is intended to affect the 
animal's structure or function meets the definition of an animal drug, whether the animal 
is intended for food, or used to produce another substance.”76 Because the application of 
rDNA is intended to affect the animal in the same way as a conventional drug, the FDA is 
in charge of its regulation. The authority to regulate new animal drugs is the most 
important part of the FDA’s analysis of new foods, because it allows the FDA to oversee 
every part of the construction of the food, as opposed only being able to regulate the 
consumer product as a whole right before it hits the market.  This is very technical and 
not very clear to a layperson. Footnotes could help explain it. 
However, this is not the only way that the FDA can assert authority over 
genetically modified animals as food. The FDA additionally has authority to regulate 
genetically modified animals as human consumption because rDNA might be considered 
                                                        
73 21 U.S.C. § 321. 
74 Id. 
75 FDA, Guidance for Industry: Regulation of Genetically Engineered Animals Containing Heritable 
Recombinant Constructs 4, 
http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforI
ndustry/ ucm113903.pdf. 
76 Id. (emphasis added). 
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an adulteration to the product.
77
 Adulteration is defined in many ways in the statute, but 
most generally, a food is considered adulterated if it “bears or contains any poisonous or 
deleterious substance which may render it injurious to [public] health.”78 Foods are not 
presumed adulterated so long as they comply with the conditions and guidelines of the 
FDA.
79
 In the same report, the FDA added harsher compliance requirements for foods 
modified with rDNA, requiring that “developers of these animals must demonstrate that 
the construct and any new products expressed from the inserted construct are safe for the 
health of the [genetically engineered] animal and, if they are food animals, for food 
consumption.”80 The FDA’s authority over whether a food is adulterated allows the FDA 
to regulate not only what composes or makes up the food, but also if the food will be 
harmful on a higher level, as a food for general human consumption. 
Once the FDA has determined that an animal applied with changed rDNA and 
grown for human consumption is safe for human consumption, it must amend the 
applicable regulations to reflect the specific product approved.
81
 Though the FDA is very 
close to approving genetically modified salmon and adding regulation to that effect, the 
only applicable example of this process resulting in created regulation in current law has 
to do with goat milk.
82
 Many scholars have surmised that the next genetically modified 
animal product that will be explicitly regulated will be the AquAdvantage Salmon, and 
                                                        
77 21 U.S.C. § 360b. 
78 21 U.S.C. § 342. 
79 Paradise, supra n.66 at 69. 
80 Guidance for Industry, supra n.74. 
81  Paradise, supra n.66 at 70. 
82 21 C.F.R. § 528.1070 
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after a 17 year process, the FDA’s own briefing packets suggest this statement will be 
true.
83
 
 i. Specific FDA Regulation of Genetically Modified Salmon 
 The FDA’s specific approach to deciding whether AAS should be allowed 
focuses on three different criteria:  “The safety of the transgenic construct for the animal; 
safety of the food from the animal; environmental impact.”84 This paper has already 
discussed the environmental impact of the AAS, and the FDA reached the same 
conclusion about the environmental impact as that reached above. [you said earlier that it 
has not yet completed its investigation]The safety of the transgenic construct is not an 
issue in this case, because there is obviously no danger to the AAS itself. The salmon 
develops and lives out its life (relatively) normally in captivity, able to do everything that 
a naturally occurring, wild salmon would.?? Is it really the same?  Additionally, even if 
the safety of the transgenic construct used in creating AAS were at issue, the FDA has 
already asserted its regulatory authority over the product and determined it completely 
safe.
85
 
Then the only remaining issue is for the FDA to determine the safety of the food 
gained from the animal. The equivalency principle lends itself very well to this analysis.
86
 
AquaBounty does meddle in the genetic process of the salmon. However, the scientific 
interference with the salmon’s natural processes does not last for longer than the zygote 
stage of its development. After that stage, AquaBounty’s only contact with their salmon 
                                                        
83 See FDA, VMAC Briefing Packet, AquAdvantage Salmon,  
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/VeterinaryMe
dicineAdvisoryCommittee/UCM224762.pdf 
84 Id. 
85 As discussed supra in the preceding paragraphs  
86 Contra Kimbrell, 18 ANIMAL L. at 97. 
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is generally to feed it and make sure that they remain captive and do not interfere with 
any population of wild salmon. AAS feed normally, and they do everything that other 
salmon do naturally in the wild, aside from reproduce. While this somewhat destroys the 
salmon’s majestic story, it does nothing to detrimentally impact ? their nutritional value. 
In fact, it only enhances the good nutritional qualities of naturally occurring salmon, 
without enhancing any of the drawbacks. This obviously passes the FDA’s second 
concern in its test, and after assuring that there is no adverse environmental impact, the 
FDA has no reason to block or otherwise restrict this kind of salmon production. 
The FDA’s approval method and general attitude towards this type of production 
in the United States can be contrasted with the European Union’s approach to genetically 
modified products in the marketplace. Historically, the European public has not been as 
accepting of genetically modified foods, sparking huge debate and resistance.
87
 European 
consumers do not believe that genetically modified foods will be safe; and, even if they 
are safe, the consumers do not believe that their government can adequately control or 
oversee genetic modification or production.
88
 
ii. European Union Regulation of Genetically Modified Food 
This public concern? has led to a different kind of principle governing European 
legislation:  The Precautionary Principle.
89
 This is the complete opposite of the United 
States’ stance. Using the precautionary principle, genetically modified food is considered 
unsafe until it can be effectively proven that there are no risks involved.
90
 Any applicant 
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seekingto produce genetically modified food must convince? the European Union that the 
product will be safe before it can even be marketed, based on part by an independent 
assessment from a third party of the food’s possible risks and rewards.91 This third party 
would be whatever “national competent authority” that each country might recognize as 
their own administrative body (comparable to the US’s FDA).92 Any producer trying to 
sell its genetically modified products in the European Union must not only comply with 
EU regulations. Additionally, producers must comply with their own national standards, 
which might even be harsher than EU regulation. EU regulation of the application itself is 
extensive, applying a heavy burden on the producer to show that its product is safe.
93
 The 
applicant must not only provide convincing details as to how the genetically modified 
food was created, stored, raised, etc.; but, also, details as to other possible concerns, such 
as inclusion of a “reasoned statement that the food does not give rise to ethical or 
religious concerns.”94 This provision alone would seem to an extremely high hurdle for 
genetically modified food to jump, as many religions are highly skeptical of genetic 
modification in the first place.fn?  How do you know this?  Naturally, the European 
Union’s stricter approach mandates much slower growth and innovation in the 
marketplace, and ultimately such stricter regulation makes it much harder for the 
modified food industry to flourish.
95
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The main difference between US and EU legislation has to do with the labeling of 
genetically modified foods.
96
 The United States does not impose labeling requirements on 
any distributor of genetically modified foods.
97
 The FDA has released voluntary 
guidelines, however,; but there is no reason for any food distributor to worry? about 
following these guidelines, save for consumer expectation.
98
 Taken with the fact that only 
1/3 of the population even knows about genetic modification of foods such as corn, there 
is really no need for companies to develop marketing plans to deal with consumer 
expectation or disapproval. This undoubtedly applies to AAS as well, as it is a genetically 
modified food. As discussed above, the FDA has assumed sole responsibility of 
regulating genetically modified animal food, and has green-lighted AAS for human 
consumption without a need for labeling.
99
 The European Union has much stricter 
labeling restrictions, requiring mandatory product labeling and ultimate transparency to 
the consumer, as well as government monitoring and public disclosure of the growing 
process.
100
 These stricter restrictions apply to any foods imported to the EU as well.
101
 In 
fact, the vast bulk of the EU regulations regarding genetically modified foods speak of 
labeling in some way or another, as most provisions include the phrase:  “or a proposal 
for labeling [sic] the food in accordance with Article…”102 [Is there some evidence that 
EU consumers care more about possible safety issues?  Has anyone tried to explain why 
the EU is so cautious?] 
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iii. United States Accommodation of European Union Guidelines 
The discrepancy between labeling may very well affect the import/export salmon 
market in the EU. Currently, 23% of the US’s salmon production is exported to the 
EU.
103
 Should AAS begin to take over a significant portion of the salmon market, the EU 
may stop buying US salmon, due to its fear of receiving a product that it deems as unsafe 
because of failure to  follow its labeling guidelines. [US companies can follow EU 
guidelines if they want to]The EU has already indicated that it would be very strict in its 
application of its regulations of international? movement of genetically modified 
organisms.
104
 For various reasons,
105
 including fear of human safety and the continued 
threat of a loss of biodiversity, the EU has implemented an expansive regulation 
regarding the import and export of genetically modified organisms.  This has  purportedly 
been done in an attempt to satisfy the Cartagena Protocol on Biosafety to the Convention 
on Biological Diversity.
106
 Not surprisingly, the United States is not a party to this 
Convention.  
However, because of the fear of losing market viability, several senators have 
criticized the FDA’s process of approving genetically modified foods and have tried to 
change the way that the process is completed, calling for stricter guidelines and labeling 
requirements.
107
 Scholars have also asserted that the gap between the US and EU concept 
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will widen and that the EU will ban any import of AAS into its territory.
108
 This should 
not be a legitimate reason for the US to consider legislation to accommodate the 
European Union. First, Europeans would not be afraid to buy traditional, Alaskan fished 
wild or farmed salmon. Voluntary labeling from Alaskan fisheries might very well be 
able to recapture the 23% market share of the European Union, mitigating? their 
declining market-share from needing to compete with AAS. Second, aside from creating 
a solution that would help out traditional Alaskan fisheries, continuing the policy of? not 
requiring labeling will remain more in line with domestic consumers’ expectations and 
the American risk assessment and efficiency model. There appears to be no reason to 
start a panic among consumers that might adversely affect the salmon industry, not to 
mention that such a panic would be started out of fear of losing more fickle? Or 
cautious?, foreign consumers. There is no reason to force our domestic consumers to bow 
to the needs of the European Union or the World Trade Organization. For obvious 
reasons, if Europeans are so frightened of our products that they feel obligated to ban 
their import, the EU should be and remains completely free to fish for their own salmon. 
Only in very grave circumstances should we in the US? allow the European system to 
dictate that our government impose unneeded restrictions and sanctions on domestic 
consumers and producers. Again, since there is no evidence of harm by the salmon to 
contradict the need for no further regulation, the free market is most likely the best judge 
of how the European consumers and American producers should act—not the meddling 
of a clearly imperfect international politic. 
An interesting aside that provides supplemental evidence on this point is the fact 
that AquaBounty is an English company, listed on the London Stock Exchange’s 
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Alternative Investment Market.
109
 However, it is currently marketing and testing its 
salmon exclusively for United States consumers. Additionally, the company has applied 
for a US patent and is currently headquartered in Massachusetts.
110
 AquaBounty will not 
even attempt to market its product in the European Union, despite being listed on their 
stock exchange. Should the AAS turn out to be a superior product than natural salmon, 
this would simply be a predictable byproduct of the principle of equivalence’s ability to 
better adapt a product to a marketplace.  
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Conclusion 
 With the advent of genetic technology, new and exciting possibilities are opening 
up for humanity. Scholars and experts have always questioned and should always 
continue to question the direction that this technology is taking us.  But while 
governmental involvement and regulation is a good thing, it should be limited to what is 
absolutely necessary. Unlike the current policy of the European Union, governmental 
intrusion should not limit the productivity or availability of products in the marketplace 
more than might be absolutely necessary. 
 AquaBounty’s salmon has been genetically modified to grow bigger and stronger 
than naturally occurring wild or farmed salmon ever will. Plus, the AquAdvantage 
salmon grow at over twice the rate of naturally occurring salmon. The FDA has 
extensively reviewed and recently approved the AquAdvantage salmon as safe for human 
consumption, after assessing their potential impact on the environment and the safety of 
the salmon to be consumed. The FDA’s review of the environmental impact has show 
that there was an infinitesimal chance that the salmon would escape into the wild and 
ravage natural salmon populations. Additionally, because there is no real difference 
between the AquAdvantage salmon and naturally occurring salmon, the FDA has 
determined that there is no reason to fear its open sale on the market. 
 The FDA has also put forth voluntary labeling guidelines for those that wish to 
represent whether their salmon has or has not been genetically modified. Unless there is a 
huge consumer outcry against genetically modified salmon,  this minimal regulation 
should be able to provide enough security and oversight to protect consumer choices. 
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There is no need for more restrictions and regulations to save consumers or to bring 
United States policy into line with the European Union’s more cautious, draconian 
regulation. Because genetically modified salmon has proven safe for human consumption 
and has virtually no negative impact on the environment, the FDA’s current regulation 
and approach is sufficient, and there is no need for anything additional. 
 
Better than original.  Still a little one-sided.  Aren’t their some scientists who may argue 
that we won’t know the full effect on human safety until there has been some long-term 
studies regarding the well-being of both the salmon and human consumers.? 
Have their been any examples where the US approach—allow until harm is shown—has 
proven disastrous?  [How about some of the pills/drugs the FDA has allowed on the 
marker.  Also there is a chance that a company such as Aqua may fake/skew reported 
findings so as to obtain approval] 
Final Grade: A- 
 
